NeoGenomics, Inc. Additional Paid in Capital, Common Stock
NeoGenomics, Inc. (NEO) had Additional Paid in Capital, Common Stock of $1.26 billion as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-07-28
- 2026-06-30: Additional Paid in Capital, Common Stock $1.26B.
- 2026-03-31: Additional Paid in Capital, Common Stock $1.28B.
- 2025-12-31: Additional Paid in Capital, Common Stock $1.27B.
- 2025-09-30: Additional Paid in Capital, Common Stock $1.26B.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2026-06-30 | $1.26B 10-Q · filed 2026-07-28 | |
| 2026-03-31 | $1.28B 10-Q · filed 2026-04-28 | |
| 2025-12-31 | $1.27B 10-Q · filed 2026-07-28 | |
| 2025-09-30 | $1.26B 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $1.25B 10-Q · filed 2025-07-29 | |
| 2025-03-31 | $1.24B 10-Q · filed 2025-04-29 | |
| 2024-12-31 | $1.23B 10-K · filed 2026-02-17 | |
| 2024-09-30 | $1.22B 10-Q · filed 2024-11-05 | |
| 2024-06-30 | $1.21B 10-Q · filed 2024-07-30 | |
| 2024-03-31 | $1.20B 10-Q · filed 2024-04-30 | |
| 2023-12-31 | $1.19B 10-K · filed 2025-02-18 | |
| 2023-09-30 | $1.18B 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $1.17B 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $1.17B 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $1.16B 10-K · filed 2024-02-20 | |
| 2022-09-30 | $1.15B 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $1.15B 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $1.14B 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $1.12B 10-K · filed 2023-02-24 | |
| 2021-09-30 | $1.11B 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $1.10B 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $872.35M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $701.36M 10-K · filed 2022-02-25 | |
| 2020-09-30 | $688.83M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $679.24M 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $525.93M 10-Q · filed 2020-04-29 | |
| 2019-12-31 | $520.28M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $516.94M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $543.48M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $378.57M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $340.29M 10-K · filed 2020-02-28 | $372.19M 10-K · filed 2019-02-26 |
| 2018-09-30 | $354.49M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $217.45M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $232.04M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $230.03M 10-K · filed 2019-02-26 | |
| 2017-09-30 | $229.01M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $220.62M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $217.63M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $216.10M 10-K · filed 2018-03-13 | |
| 2016-09-30 | $238.97M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $236.18M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $233.40M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $231.50M 10-K · filed 2017-03-14 | $231.38M 10-K · filed 2016-03-15 |
| 2015-09-30 | $82.26M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $81.15M 10-Q · filed 2015-07-31 | |
| 2015-03-31 | $80.26M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $79.75M 10-K · filed 2016-04-18 | |
| 2014-09-30 | $79.46M 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $43.24M 10-Q · filed 2014-07-29 | |
| 2014-03-31 | $42.88M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $42.20M 10-K · filed 2015-03-03 | |
| 2013-09-30 | $41.67M 10-Q · filed 2013-10-30 | |
| 2013-06-30 | $41.69M 10-Q · filed 2013-08-02 | |
| 2013-03-31 | $41.35M 10-Q · filed 2013-05-13 | |
| 2012-12-31 | $31.74M 10-K · filed 2014-02-24 | |
| 2012-09-30 | $31.64M 10-Q · filed 2012-11-05 | |
| 2012-06-30 | $31.16M 10-Q/A · filed 2012-08-15 | |
| 2012-03-31 | $30.66M 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $28.49M 10-K · filed 2013-02-21 | |
| 2011-09-30 | $28.11M 10-Q · filed 2011-10-25 | |
| 2011-06-30 | $27.89M 10-Q/A · filed 2011-08-01 | |
| 2010-12-31 | $24.56M 10-K · filed 2012-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |